James Haynes

University of Tennessee at Chattanooga

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

J. M. Maur

Barcelona Biomedical Research Park

Henn Kutt

Cornell University

Barbara Jamieson

Cape Breton University

Fletcher McDowell

Center for Translational Molecular Medicine

J. R. Beaton

University of Wisconsin–Green Bay

Gregory W. Heath

University of Tennessee at Chattanooga

Victor O. Kolade

Guthrie Robert Packer Hospital

Robert K. Persons

Eglin Air Force Base

D. M. McComiskey

I. Ringler

Pearl River Community College

Cooperative Institutions

University of Tennessee at Chattanooga

University of Tennessee Health Science Center

Cornell University

Queen's Medical Centre

University of Nottingham

Eglin Air Force Base

United States Department of Defense

Harvard University

Queen's University

University of Washington

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Evaluation of asymptomatic atrial fibrillation.

PubMed (2012)

Adam Newell James Haynes Rita Smith

In hemodynamically stable patients without acute chest pain, the evaluation and treatment of atrial fibrillation should not change based on symptoms alone.

Source

Cite

Citations (3)

Clinical inquiries. Which patients undergoing noncardiac surgery benefit from perioperative beta-blockers?

James Haynes Gary Kelsberg Barbara Jamieson Ló

BETA (programming language)

Source

Cite

Citations (0)

Bioassay of Adrenocorticosteroids by the Dog Eosinophil Response

Experimental Biology and Medicine (1964)

G. Tonelli James Haynes E Heyder I. Ringler

Several glucocorticoids were administered orally or intravenously to fasted, intact dogs and their effects on circulating eosinophils determined. The calculated eosinopenic potencies were not quantitatively related to those reported in man. The Possible implication of these data with respect to dosage selection of steroids for studies in dogs is briefly discussed.

10.3181/00379727-116-29291

Cite

Citations (1)

The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes

Neurology (1969)

Henn Kutt James Haynes Karl Verebely Fletcher McDowell

Phenobarbital

10.1212/wnl.19.6.611

Cite

Citations (79)

Non-Hodgkin's lymphoma

Stephen Greer James Haynes

Source

Cite

Citations (0)

How common is symptomatic hyponatremia in endurance athletes?

Evidence-Based Practice (2014)

Erik R. Clauson James Haynes

Evidence-Based Answer Symptomatic exercise-associated hyponatremia (EAH) as seen in 0% to 1.1% of endurance athletes, typically manifesting as neurologic symptoms ranging from dizziness, headache, and lethargy to seizures and death (SOR C, cohort studies).

Lethargy

10.1097/01.ebp.0000540698.81146.4a

Cite

Citations (0)

Cognitive Behavioral Therapy in the Treatment of Insomnia

Southern Medical Journal (2018)

James Haynes Malissa Talbert Stephen B. Fox Elizabeth Close

The information in

Sleep hygiene

Sleep restriction

Pharmacotherapy

Relaxation Therapy

Sleep onset latency

10.14423/smj.0000000000000769

Cite

Citations (46)

Preparation and Luminescence of Selected Eu3+-Activated Rare Earth-Oxygen-Sulfur Compounds

Journal of The Electrochemical Society (1968)

James Haynes Jesse J. Brown

The hydrated sulfate, sulfate, oxysulfate, and oxysulfide compounds of yttrium, lanthanum, gadolinium, and lutetium were prepared using precipitation techniques and controlled atmosphere high temperature heat treatments. The temperature stability range in air for each compound was investigated by DTA and TGA methods. X‐ray diffraction powder data are presented for the fourteen compounds isolated. The only compounds that showed significant Eu3+‐activated luminescence were the oxy sulfates and oxysulfides. , the most efficient phosphor examined, is as bright as and distinctly more "red." Luminescence data are presented and discussed.

Lanthanum

Lutetium

Thermal Stability

Atmospheric temperature range

10.1149/1.2410877

Cite

Citations (64)

What medications are safe and effective in pediatric patients with depression?

Evidence-Based Practice (2016)

James Haynes Michael Shepherd

Evidence-Based Answer Escitalopram is likely the most consistently efficacious medication in treating multiple aspects of pediatric depression (SOR: A, meta-analyses of RCTs). Paroxetine and citalopram appear to be ineffective in treating pediatric depression. All medications slightly increase the risk of suicidal ideation and behavior, with sertraline having the highest risk and mirtazapine and escitalopram having the lowest risk (SOR: B, metaanalyses of RCTs with heterogeneity).

Escitalopram

Mirtazapine

Citalopram

Sertraline

Paroxetine

Depression

10.1097/01.ebp.0000541513.12992.b5

Cite

Citations (0)

Hodgkin's lymphoma

James Haynes Stephen Greer

Source

Cite

Citations (1)